Core Viewpoint - Neogen Corporation (NASDAQ: NEOG) is facing a class action lawsuit due to allegations of issuing materially false and misleading statements regarding its integration with the Food Safety Division of 3M Company, which misled investors about the progress of the integration [3]. Group 1: Allegations and Class Action Details - The class period for the lawsuit is from January 5, 2023, to June 3, 2025 [3]. - Defendants allegedly downplayed inefficiencies arising from the integration and assured investors of their commitment to resolving these issues quickly [3]. - Shareholders are encouraged to register for the class action by September 16, 2025, to potentially become lead plaintiffs [4]. Group 2: Law Firm Information - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and fraud [5]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [5].

Contact Us To Participate or Learn More: If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us. The Law Offices of Frank R. Cruz, Email us at: [email protected] Call us at: 310-914-5007 Visit our website at: www.frankcruzlaw.com Follow us for updates on Twitter: twitter.com/FRC_LAW. If you inquire by email, please include your mailing address, telephone number, and number of shares p ...

NEW YORK, Aug. 4, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Neogen Corporation (NASDAQ: NEOG).Shareholders who purchased shares of NEOG during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/neogen-corporation-loss-submission-form/?id=159225&from=4 CLASS PERIOD: January 5, 2023 ...

Core Viewpoint - Neogen Corporation is facing a class action lawsuit due to alleged violations of the Securities Exchange Act of 1934, with claims that the company and its executives misled investors regarding the integration with 3M and the financial health of the company during the class period from January 5, 2023, to June 3, 2025 [1][3]. Company Overview - Neogen Corporation, along with its subsidiaries, specializes in the development, manufacture, and marketing of products and services focused on food and animal safety [2]. Allegations of the Lawsuit - The lawsuit claims that Neogen's executives made false or misleading statements about the progress of the integration with 3M, leading investors to believe it was more successful than it was [3]. - It is alleged that when Neogen disclosed "inefficiencies" from the integration, the executives downplayed these issues and assured investors of their commitment to resolving them [3]. Financial Performance - On January 10, 2025, Neogen reported a significant GAAP net income loss due to a $461 million non-cash goodwill impairment charge related to the 3M acquisition, alongside a reduction in fiscal year 2025 revenue and EBITDA guidance [4]. - Following this announcement, Neogen's stock price dropped over 5% [4]. - On April 9, 2025, Neogen reported a loss of $11 million for the third quarter of 2025, a significant increase from a loss of $2 million the previous year, with revenue falling 3.4% to $221 million due to integration issues [5]. - This news led to a 28% decline in Neogen's stock price [5]. - On June 4, 2025, Neogen projected an EBITDA margin drop to the high teens from 22%, attributing the decline to elevated inventory write-offs, resulting in a further stock price drop of over 17% [6]. Legal Process - Investors who purchased Neogen common stock during the class period can seek appointment as lead plaintiff in the class action lawsuit, representing the interests of all class members [7].

Core Points - Rosen Law Firm is reminding purchasers of Neogen Corporation common stock from January 5, 2023, to June 3, 2025, about the September 16, 2025, lead plaintiff deadline for a class action lawsuit [1] - Investors who purchased Neogen stock during the specified period may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [1] Class Action Details - A class action lawsuit has already been filed against Neogen Corporation, and interested parties can join by submitting a form or contacting the law firm [2][5] - The lawsuit alleges that Neogen's management made false and misleading statements regarding the integration process, leading investors to believe it was progressing well when it was not [4] - The lawsuit claims that when the true situation was revealed, investors suffered damages due to the misleading information provided by the defendants [4] Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [3] - The firm has achieved significant settlements in the past, including over $438 million for investors in 2019 and has been ranked highly in securities class action settlements since 2013 [3]

Core Viewpoint - Neogen Corporation is facing a class action lawsuit due to alleged violations of the Securities Exchange Act of 1934, with claims that the company and its executives misled investors regarding the integration with 3M and the financial health of the company during the class period from January 5, 2023, to June 3, 2025 [1][3]. Company Overview - Neogen Corporation, along with its subsidiaries, specializes in the development, manufacture, and marketing of products and services focused on food and animal safety [2]. Allegations of the Lawsuit - The lawsuit claims that Neogen's executives made false or misleading statements about the progress of the integration with 3M, leading investors to believe it was more successful than it was [3]. - It is alleged that when Neogen disclosed "inefficiencies" from the integration, the executives downplayed these issues and assured investors of their commitment to resolving them [3]. Financial Performance and Impact - On January 10, 2025, Neogen reported a significant GAAP net income loss due to a $461 million non-cash goodwill impairment charge related to the 3M acquisition, leading to a more than 5% drop in stock price [4]. - The third quarter results on April 9, 2025, showed a loss of $11 million, a revenue decline of 3.4% to $221 million, and a 28% drop in stock price following the announcement [5]. - On June 4, 2025, Neogen projected an EBITDA margin drop to the high teens from 22%, resulting in a more than 17% decline in stock price [6]. Lead Plaintiff Process - The Private Securities Litigation Reform Act of 1995 allows any investor who purchased Neogen common stock during the class period to seek appointment as lead plaintiff, representing the interests of the class [7]. Law Firm Background - Robbins Geller Rudman & Dowd LLP is a leading law firm in securities fraud and shareholder litigation, having recovered over $2.5 billion for investors in 2024 alone [8][9].

Core Viewpoint - Neogen Corporation is facing a class action securities lawsuit due to alleged securities fraud that misled investors regarding the integration with 3M Company's Food Safety Division [1][2]. Group 1: Lawsuit Details - The lawsuit seeks to recover losses for investors affected by misleading statements made between January 5, 2023, and June 3, 2025 [1]. - Defendants allegedly issued materially false statements about the integration's progress and downplayed inefficiencies that arose during the process [2]. Group 2: Next Steps for Investors - Investors who suffered losses during the specified timeframe have until September 16, 2025, to request to be appointed as lead plaintiff [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees [3]. Group 3: Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and is recognized as one of the top securities litigation firms in the U.S. [4].

Core Viewpoint - Neogen Corporation is facing a class action securities lawsuit due to alleged securities fraud that misled investors regarding the integration with 3M Company's Food Safety Division [1][2]. Group 1: Lawsuit Details - The lawsuit seeks to recover losses for investors affected by misleading statements made between January 5, 2023, and June 3, 2025 [1]. - Defendants allegedly issued materially false statements about the integration's progress and downplayed inefficiencies that arose during the process [2]. Group 2: Next Steps for Investors - Investors who suffered losses during the specified timeframe have until September 16, 2025, to request appointment as lead plaintiff [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees [3]. Group 3: Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and is recognized as one of the top securities litigation firms in the U.S. [4].

LOS ANGELES, July 31, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming September 16, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Neogen Corporation ("Neogen" or the "Company") (NASDAQ: NEOG) common stock between January 5, 2023 and June 3, 2025, inclusive (the "Class Period"). IF YOU SUFFERED A LOSS ON YOUR NEOGEN INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO ...

Group 1 - The Rosen Law Firm is reminding purchasers of Neogen Corporation common stock from January 5, 2023, to June 3, 2025, about the September 16, 2025, lead plaintiff deadline for a class action lawsuit [1] - Investors who purchased Neogen common stock during the specified period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1][2] - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must act by the September 16, 2025, deadline [2] Group 2 - The lawsuit alleges that Neogen's defendants made false and misleading statements regarding the integration process, leading investors to believe it was progressing smoothly [4] - At the start of the Class Period, defendants claimed the integration was "off to a great start" and that Neogen was experiencing solid core growth and profitability [4] - The lawsuit claims that when the true details of the integration issues became known, investors suffered damages [4] Group 3 - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [3] - The firm has achieved significant settlements for investors, including over $438 million in 2019 and has been ranked highly for its performance in securities class action settlements [3] - Founding partner Laurence Rosen was recognized as a Titan of Plaintiffs' Bar by Law360 in 2020, highlighting the firm's reputation in the industry [3]